06.10.2015 • News

Merged Dow-Olin Names New Executives

Dow Chemical and Olin Corporation completed their chlor-alkali, chlorinated organics and epoxy asset merger at the beginning of the third quarter and have appointed new executives to the combined company that will operate under the Olin umbrella.

The two new directors, designated by Dow in connection with the Reverse Morris Trust transaction, are William H. Weideman and Carol A. Williams.

During his 38 years at Dow, Weideman, 61, served in senior financial and management roles across Dow's portfolio of businesses and in his last position was chief financial officer and executive vice president from March 2010 to January 2015. He is also on the board of directors of Sadara Chemical Company, the joint venture with SABIC.

Williams, 57, served as a special advisor to the Dow CEO Andrew Liveris until early 2015. Prior to this, she was the chemical giant’s executive vice president of manufacturing and engineering, supply chain and environmental, health & safety operations. In an earlier position she was vice president for the North American chlor-alkali business.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read